Back to Louisiana

HB1154 • 2026

INSURANCE: Prohibits prior authorizations requirements for certain generic medications prescribed by qualified physicians (EN NO IMPACT GF EX See Note)

INSURANCE: Prohibits prior authorizations requirements for certain generic medications prescribed by qualified physicians (EN NO IMPACT GF EX See Note)

Budget Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Brian Glorioso
Last action
2026-05-27
Official status
Sent to Governor
Effective date
Not listed

Plain English Breakdown

The official source material did not provide specific details about the effective date or any limitations beyond those explicitly stated in the summary and text.

Insurance Law Change for Generic Medications

This bill stops insurance companies from requiring prior approval before paying for certain generic medications prescribed by qualified doctors.

What This Bill Does

  • Adds new rules to Louisiana's insurance laws about when insurers can require prior authorization for generic drugs.
  • Defines a 'board-certified physician' as a doctor licensed in Louisiana who is certified by recognized medical boards.
  • Specifies that a 'generic medication' is a drug approved by the FDA as chemically equivalent and interchangeable with brand-name drugs.
  • Requires commercial insurers to cover generic medications without prior authorization if they meet certain conditions.

Who It Names or Affects

  • People who have health insurance in Louisiana
  • Doctors who prescribe medications
  • Insurance companies that offer health plans in Louisiana

Terms To Know

Board-certified physician
A doctor licensed to practice medicine in Louisiana and certified by recognized medical boards.
Commercial insurer
An insurance company that offers health plans covering prescription drugs in Louisiana, excluding government programs like Medicaid.

Limits and Unknowns

  • The bill does not apply to medications costing more than $250 per prescription.
  • It only applies to generic medications and not brand-name drugs or opioids.
  • Insurance companies must comply with the new rules by January 1, 2028.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Plain English: HFAHB1154 4878 4959 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Glorioso to Reengrossed House Bill No.

  • HFAHB1154 4878 4959 FOR OFFICE USE ONLY HOUSE FLOOR AMENDMENTS 2026 Regular Session Amendments proposed by Representative Glorioso to Reengrossed House Bill No.
  • 1154 by Representative Glorioso AMENDMENT NO.
  • 1 On page 1, line 4, after "physicians" and before the semi-colon ";" insert "or authorized providers" 1 AMENDMENT NO.
  • 2 2 On page 2, line 11, after "physician" insert "or authorized provider" Page 1 of 1 CODING: Words in struck through type are deletions from existing law; words underscored are additions.

Plain English: HCAHB1154 4448 4567 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Appropriations to Engrossed House Bill No.

  • HCAHB1154 4448 4567 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Appropriations to Engrossed House Bill No.
  • 1154 by Representative Glorioso 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "through (12)" and before "relative" delete "and 1060.9 and R.S.
  • 3 46:153.3.3," and insert "and 1060.9," 4 AMENDMENT NO.

Plain English: HCAHB1154 4448 4470 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Appropriations to Engrossed House Bill No.

  • HCAHB1154 4448 4470 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Appropriations to Engrossed House Bill No.
  • 1154 by Representative Glorioso 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "through (12)" and before "relative" delete "and 1060.9 and R.S.
  • 3 46:153.3," and insert "and 1060.9," 4 AMENDMENT NO.

Plain English: HCAHB1154 4878 3847 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.

  • HCAHB1154 4878 3847 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.
  • 1154 by Representative Glorioso 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "(12)" and before "1060.9" delete the comma "," and insert "and" 3 AMENDMENT NO.
  • 2 4 On page 2, line 12, after "medication" and before "if" insert "that is not an opioid," 5 AMENDMENT NO.

Plain English: HCAHB1154 4878 3699 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.

  • HCAHB1154 4878 3699 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.
  • 1154 by Representative Glorioso 1 AMENDMENT NO.
  • 1 2 On page 2, line 12, after "medication" and before "if" insert "that is not an opioid," 3 AMENDMENT NO.
  • 2 4 On page 2, line 14, after "prescribed" and before the period "." insert "and the wholesale 5 acquisition cost is no more than two hundred fifty dollars per prescription" 6 AMENDMENT NO.

Plain English: HCAHB1154 4878 3722 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.

  • HCAHB1154 4878 3722 HOUSE COMMITTEE AMENDMENTS 2026 Regular Session Amendments proposed by House Committee on Insurance to Original House Bill No.
  • 1154 by Representative Glorioso 1 AMENDMENT NO.
  • 1 2 On page 1, line 2, after "(12)" and before "1060.9" delete the comma "," and insert "and" 3 AMENDMENT NO.
  • 2 4 On page 2, line 22, change "Subsection" to "Section" Page 1 of 1 CODING: Words in struck through type are deletions from existing law; words underscored are additions.

Bill History

  1. 2026-05-27 H

    Sent to the Governor for executive approval.

  2. 2026-05-26 S

    Signed by the President of the Senate.

  3. 2026-05-26 H

    Enrolled and signed by the Speaker of the House.

  4. 2026-05-26 H

    Received from the Senate without amendments.

  5. 2026-05-25 S

    Rules suspended. Read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

  6. 2026-05-18 S

    Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

  7. 2026-05-14 S

    Read by title and referred to the Legislative Bureau.

  8. 2026-05-13 S

    Reported favorably.

  9. 2026-05-07 S

    Read second time by title and referred to the Committee on Insurance.

  10. 2026-05-06 S

    Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

  11. 2026-05-05 H

    Read third time by title, amended, roll called on final passage, yeas 101, nays 0. Finally passed, title adopted, ordered to the Senate.

  12. 2026-04-29 H

    Scheduled for floor debate on 05/05/2026.

  13. 2026-04-28 H

    Read by title, amended, ordered reengrossed, passed to 3rd reading.

  14. 2026-04-27 H

    Reported with amendments (13-0).

  15. 2026-04-16 H

    Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations.

  16. 2026-04-15 H

    Reported with amendments (13-0).

  17. 2026-04-01 H

    Read by title, under the rules, referred to the Committee on Insurance.

  18. 2026-03-31 H

    Read by title. Lies over under the rules.

Official Summary Text

INSURANCE: Prohibits prior authorizations requirements for certain generic medications prescribed by qualified physicians (EN NO IMPACT GF EX See Note)

Current Bill Text

Read the full stored bill text
ENROLLED
2026 Regular Session
HOUSE BILL NO. 1154
BY REPRESENTATIVES GLORIOSO, AMEDEE, BAYHAM, BERAULT, WILFORD
CARTER, CHASSION, CHENEVERT, EGAN, FREIBERG, HORTON, MILLER,
OWEN, TAYLOR, AND WALTERS
1 AN ACT
2 To enact R.S. 22:1060.1(9) through (12) and 1060.9, relative to prior authorizations for
3 medications: to provide for requirements for certain generic medications prescribed
4 by qualified physicians or authorized providers; to provide for definitions; to require
5 health insurance coverage for medication; to provide for applicability; and to provide
6 for related matters.
7 Be it enacted by the Legislature of Louisiana:
8 Section 1. R.S. 22:1060.1 (9) through (12) and 1060.9 are hereby enacted to read as
9 follows:
10 §1060.1. Definitions
11 As used in this Subpart, the following definitions apply:
12 * * *
13 (9) "Board-certified physician" means a physician licensed to practice
14 medicine in this state who is certified by a member board of the American Board of
15 Medical Specialties or an equivalent certifying body recognized by the Louisiana
16 State Board of Medical Examiners.
17 (10) "Commercial insurer" means any health insurance issuer, health
18 maintenance organization, or other entity that offers a health benefit plan through a
19 policy, contract, or certificate of insurance that covers prescription drugs and is
20 authorized to provide health insurance coverage in this state, excluding federal, state,
21 or local governmental plans such as Medicaid.
Page 1 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HB NO. 1154 ENROLLED
1 (11) "Generic medication" means a drug that is chemically equivalent to a
2 brand-name drug and approved by the United States Food and Drug Administration
3 as interchangeable.
4 (12) "Prior authorization" means a utilization review process requiring
5 approval from the insurer before a prescribed medication can be dispensed or
6 reimbursed.
7 * * *
8 §1060.9. Prohibition on prior authorization for generic medications; conditions
9 A commercial insurer shall not require prior authorization for the dispensing
10 or reimbursement of a generic medication that is not an opioid, if the prescription for
11 the medication is issued by a board-certified physician or authorized provider whose
12 specialty certification includes the medical indication for which the drug is
13 prescribed and the wholesale acquisition cost is no more than two hundred fifty
14 dollars per prescription.
15 Section 2. The provisions of this Act shall apply to any new policy, contract, or
16 health coverage plan issued on and after January 1, 2027. Any policy, contract, or health
17 coverage plan in effect prior to January 1, 2027, shall convert to conform to the provisions
18 of this Act on or before the renewal date, but no later than January 1, 2028.
SPEAKER OF THE HOUSE OF REPRESENTATIVES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 2 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.